AI English summary of an SEC filing — figures as filed
The company said it will present at the Barclays 27th Annual Global Healthcare Conference on Wednesday, March 12, 2025 at 2:30 p.m. EDT.
Key points
AI summaryThe company said it will present at the Barclays 27th Annual Global Healthcare Conference on Wednesday, March 12, 2025 at 2:30 p.m. EDT.
Centene said it expects to reaffirm its previously issued 2025 adjusted diluted earnings per share (EPS) annual guidance of greater than $7.25 during the presentation.
The company said a simultaneous live audio webcast of the presentation on March 12 will be available, and a replay will be available after the presentation on the Investors section of its website at www.centene.com.
Centene said it cannot provide a reconciliation of its 2025 adjusted diluted EPS guidance to the most directly comparable GAAP measure without unreasonable effort, because it is difficult to predict the timing and amounts of various items within a reasonable range.
Summary
AI-writtenAnalysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.
Barclays Conference Presentation Schedule
The company said it will present at the Barclays 27th Annual Global Healthcare Conference on Wednesday, March 12, 2025 at 2:30 p.m. EDT.
Source · Based on the filing body and exhibits
Centene Reaffirms 2025 Adjusted Diluted EPS Annual Guidance
Centene said it expects to reaffirm its previously issued 2025 adjusted diluted earnings per share (EPS) annual guidance of greater than $7.25 during the presentation.
Source · Based on the filing body and exhibits
Webcast Live and Replay Information
The company said a simultaneous live audio webcast of the presentation on March 12 will be available, and a replay will be available after the presentation on the Investors section of its website at www.centene.com.
Source · Based on the filing body and exhibits
No GAAP Reconciliation for Adjusted EPS Guidance
Centene said it cannot provide a reconciliation of its 2025 adjusted diluted EPS guidance to the most directly comparable GAAP measure without unreasonable effort, because it is difficult to predict the timing and amounts of various items within a reasonable range.
Source · Based on the filing body and exhibits
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…